Connacht Asset Management »

Crinetics Pharmaceuticals In shares owned by Connacht Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Connacht Asset Management from 13F filings

Historical chart of Connacht Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Connacht Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Connacht Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $217k 7.3k 29.74
2023-06-30 $224k 12k 18.02
2023-03-31 $215k 13k 16.06
2022-12-31 $226k 12k 18.30
2022-09-30 $297k 15k 19.64
2022-06-30 $210k 11k 18.62